What is the optimal tyrosine kinase inhibitor for adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia?

Fadi G. Haddad, Nicholas J. Short

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'What is the optimal tyrosine kinase inhibitor for adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia?'. Together they form a unique fingerprint.

Medicine & Life Sciences